We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of convalescent plasma therapy in SARS patients in Hong Kong.
- Authors
Cheng, Y; Wong, R; Soo, Y O Y; Wong, W S; Lee, C K; Ng, M H L; Chan, P; Wong, K C; Leung, C B; Cheng, G
- Abstract
In order to evaluate the efficacy of convalescent plasma therapy in the treatment of patients with severe acute respiratory syndrome (SARS), 80 SARS patients were given convalescent plasma at Prince of Wales Hospital, Hong Kong, between 20 March and 26 May 2003. Good outcome was defined as discharge by day 22 following the onset of SARS symptoms. Poor outcome was defined as death or hospitalization beyond 22 days. A higher day-22 discharge rate was observed among patients who were given convalescent plasma before day 14 of illness (58.3% vs 15.6%; P<0.001) and among those who were PCR positive and seronegative for coronavirus at the time of plasma infusion (66.7% vs 20%; P=0.001).
- Publication
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Vol 24, Issue 1, p44
- ISSN
0934-9723
- Publication type
Journal Article
- DOI
10.1007/s10096-004-1271-9